Plus Therapeutics (PSTV) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 9:01 A.M. Eastern Time on May 14, 2026, chaired by the President and CEO.

• Agenda included consideration of proposals set forth in the proxy statement dated March 31, 2026.

• No Q&A session was held; stakeholders were directed to investor relations for questions.

Board and executive committee updates

• Proposal to elect six members to the board for one-year terms was presented and approved.

Shareholder proposals

• Four proposals were considered: board election, ratification of auditors, advisory vote on executive compensation, and amendment of the 2020 Stock Incentive Plan.

• The adjournment proposal was not brought to the floor.